Literature DB >> 29067499

Prognosis of surgical treatment of the tethered cord syndrome in children.

Kirill Sysoev1, Arsen Tadevosyan2, Konstantin Samochernykh2, William Khachatryan2.   

Abstract

PURPOSE: The aim of this study was to identify the factors relevant to the prognosis of the outcome of the surgical treatment of the tethered cord syndrome (TCS).
METHODS: The results of surgical treatment performed on 58 children with TCS were analyzed, with follow-up periods ranging from 6 months to 5 years. The data of preoperative clinical and instrumental examinations, as well as those of intraoperative electrophysiological diagnostics and morphometry, were compared with the dynamics of the TCS clinical presentation.
RESULTS: The recovery rate was significantly higher in children with filum terminale abnormality (p = 0.014), as well as grade I tethering (p = 0.0037), and when the spinal cord tracts at the level of intervention were intact (p = 0.018). Complete untethering (p = 0.04) and a low threshold value of amperage in direct stimulation (< 1 mA) (p = 0.016) were identified as factors for a favorable outcome. Worsening of neurological symptoms was more frequent in children operated over the age of 10 (p = 0.03), when the TCS was manifested exclusively through the pelvic dysfunction (p = 0.00004), if the F-wave block is less than 30% (p = 0.0045) and the stimulation threshold during root mapping ranged from 1 to 5 mA (p = 0.01).
CONCLUSION: The operation is recommended when structural changes are minimal. In case of severe structural changes, if the spinal cord tracts are intact, the indications for operation are determined by the risk of irreversible structural changes due to the natural course of the disease, although the risks are substantially higher.

Entities:  

Keywords:  Predicting factors; Surgical treatment; Tethered cord syndrome

Mesh:

Year:  2017        PMID: 29067499     DOI: 10.1007/s00381-017-3630-8

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  13 in total

1.  What is the true tethered cord syndrome?

Authors:  Shokei Yamada; Daniel J Won
Journal:  Childs Nerv Syst       Date:  2007-01-17       Impact factor: 1.475

Review 2.  Surgical management of the tethered spinal cord--walking the fine line.

Authors:  James M Drake
Journal:  Neurosurg Focus       Date:  2007       Impact factor: 4.047

Review 3.  Recurrent tethered cord: radiological investigation and management.

Authors:  Massimo Caldarelli; Alessandro Boscarelli; Luca Massimi
Journal:  Childs Nerv Syst       Date:  2013-09-07       Impact factor: 1.475

Review 4.  Occult tethered cord syndrome: a review.

Authors:  Albert Tu; Paul Steinbok
Journal:  Childs Nerv Syst       Date:  2013-09-07       Impact factor: 1.475

5.  Preoperative predictors for improvement after surgical untethering in occult tight filum terminale syndrome.

Authors:  Andrew J Fabiano; Mohammed F Khan; Curtis J Rozzelle; Veetai Li
Journal:  Pediatr Neurosurg       Date:  2009-07-17       Impact factor: 1.162

6.  Surgical treatment of late neurological deterioration in children with myelodysplasia.

Authors:  M Caldarelli; C Di Rocco; C Colosimo; G Fariello; M Di Gennaro
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

7.  A proposed grading and scoring system for spina bifida: Spina Bifida Neurological Scale (SBNS)

Authors:  S Oi; S Matsumoto
Journal:  Childs Nerv Syst       Date:  1992-09       Impact factor: 1.475

8.  [Surgical treatment outcomes in children with tethered spinal cord syndrome. A prognosis on the basis of spinal 3T MRI tractography].

Authors:  K V Sysoev; A R Tadevosyan; Yu V Nazinkina; V A Khachatryan
Journal:  Zh Vopr Neirokhir Im N N Burdenko       Date:  2016

9.  Evaluation of surgery for the tethered cord syndrome using a new grading system.

Authors:  R W Kirollos; P T Van Hille
Journal:  Br J Neurosurg       Date:  1996-06       Impact factor: 1.596

10.  Tethered cord release: a long-term study in 114 patients.

Authors:  Robin M Bowman; Avinash Mohan; Joy Ito; Jason M Seibly; David G McLone
Journal:  J Neurosurg Pediatr       Date:  2009-03       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.